Orabloc Forte (Articaine Hydrochloride, Epinephrine)

Articaine hydrochloride blocks voltage‑gated sodium channels on nerve membranes, preventing the generation and propagation of nerve impulses. This inhibition stops pain signals from reaching the brain. Epinephrine, added to the formulation, constricts local blood vessels, decreasing blood flow at the injection site, which prolongs the anesthetic effect and limits systemic absorption.

The specific dose of Orabloc Forte is determined by the prescribing dentist or oral surgeon based on the procedure, patient weight, and medical history. Clinicians calculate the amount needed to stay within the recommended maximum dose for articaine, ensuring effective anesthesia while minimizing the risk of toxicity.

The pregnancy category for articaine with epinephrine is not definitively established. Use during pregnancy or lactation should only occur when the expected benefit justifies any potential risk to the fetus or infant. Healthcare providers should discuss individual circumstances with the patient and consider alternative options when appropriate.

To order Orabloc Forte, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Compared with lidocaine, articaine has a slightly higher lipid solubility, which can result in faster onset and deeper penetration into bone. The addition of epinephrine extends the duration of action, similar to other vasoconstricted formulations. Clinicians may prefer articaine for procedures requiring profound anesthesia in a short time, while still monitoring for its specific safety profile.

Orabloc Forte should be stored at room temperature, below 25 °C, in its original sealed container. Protect the solution from direct sunlight, moisture, and extreme temperatures. Do not freeze the product, and avoid shaking the vial vigorously before use to maintain solution integrity.

The product is supplied as a sterile solution for intraoral injection. The clinician injects the appropriate volume into the targeted tissue using a standard dental syringe and needle, following aseptic technique. The anesthetic effect typically begins within 1–3 minutes, providing sufficient time for the planned dental or surgical procedure.

Serious risks include allergic reactions that can progress to anaphylaxis, methemoglobinemia (a rare blood disorder), cardiovascular events such as hypertension or arrhythmias due to epinephrine, prolonged nerve injury, and seizures from excessive systemic absorption. Patients should be monitored closely, and any signs of these reactions require immediate medical attention.

Orabloc Forte should be avoided in individuals with a known hypersensitivity to articaine, other amide‑type local anesthetics, or epinephrine. It is also contraindicated in patients with uncontrolled severe hypertension, certain cardiac arrhythmias, or those taking monoamine oxidase inhibitors without appropriate medical supervision.